Explore live data

Market evolution: Azo compounds (CN 2927) — 2015–2025

Introduction

This report examines the evolution of EU external trade in Diazo-, azo- or azoxy-compounds (Customs code 2927) over the 2015–2025 period. These organic chemicals are widely used as intermediates in the dye, pigment, pharmaceutical, and agrochemical industries. The EU is structurally a net importer of these compounds, but the trade profile has shifted considerably over the decade — with rising import dependence, growing market concentration, and significant price and geopolitical shocks reshaping trade flows. The analysis below draws on EU Trade Dashboard data covering imports, exports, production, concentration, volatility, and vulnerability indicators.


I. A decade of growing import dependence and diverging price dynamics

The EU trade deficit remained broadly stable in value despite volume declines

Over 2015–2025, EU imports of azo compounds consistently outpaced exports by a wide margin. Import value declined modestly from €64.2 million to €61.2 million (−4.7%), while export value fell from €20.8 million to €19.2 million (−8.0%). The resulting trade deficit narrowed slightly from −€43.4 million to −€42.0 million (+3.2% improvement). However, the underlying volume trends tell a more nuanced story:

Indicator 2015 2025 Change (%)
Import value (€M) 64.2 61.2 −4.7%
Import quantity (t) 17,582 16,738 −4.8%
Export value (€M) 20.8 19.2 −8.0%
Export quantity (t) 2,080 1,629 −21.7%
Trade balance (€M) −43.4 −42.0 +3.2%

Import volumes and values moved in near-lockstep (−4.8% vs. −4.7%), indicating stable unit prices. By contrast, export volumes contracted by 21.7% while export values fell only 8.0%.

Export unit prices rose sharply while import prices stagnated

This divergence reflects a significant repricing of EU exports. The average export price climbed from €9,924/t in 2015 to €11,693/t in 2025 (+17.8%), reaching a peak of €12,400/t along the way. Meanwhile, import prices remained essentially flat at around €3,652/t. This price gap — EU exports commanding roughly three times the unit value of imports — suggests that the EU increasingly specialises in higher-value, lower-volume azo products (e.g. pharmaceutical intermediates or specialty dyes), while importing commodity-grade compounds in bulk.

Metric 2015 2025 Change (%)
Export price (€/t) 9,924 11,693 +17.8%
Import price (€/t) 3,651 3,652 ~0%

Net import reliance surged as domestic production volumes grew but collapsed in value

Perhaps the most striking structural shift is the dramatic rise in net import reliance, which surged from 15.6% in 2015 to 71.7% in 2025 (+360%). Trade intensity also increased from 58.0% to 96.2%. At the same time, EU production showed a paradoxical pattern: volumes rose from 1,050 tonnes to 1,617 tonnes (+54.1%), but reported production value plummeted from €105.1 million to €20.5 million (−80.5%). This divergence may reflect data-reporting changes, a shift in the product mix captured under this code, or a genuine collapse in domestic pricing power — though the magnitude warrants caution about possible methodological breaks in the underlying PRODCOM data.


II. Shifting trade partners and rising supply-chain concentration

China and Indonesia consolidated their dominance on the import side

The EU's import landscape for azo compounds is heavily anchored in Asia. By 2025, the top two import partners — China and Indonesia — together accounted for nearly three-quarters of total imports by value:

Partner 2015 (€M) 2025 (€M) Change (%) 2025 share
China 21.9 26.0 +18.7% ~43%
Indonesia 17.9 18.8 +4.8% ~31%
India 6.0 5.2 −13.2% ~9%
United States 7.9 3.1 −61.3% ~5%
Hong Kong 0.1 1.6 +1,221% ~3%
United Kingdom 0.9 1.6 +84.6% ~3%
Korea, Republic of 2.3 1.5 −37.6% ~2%

China strengthened its leading position, growing its share by nearly a fifth. Indonesia remained a stable, high-volume supplier. Several notable shifts occurred elsewhere: US exports to the EU fell by over 60%, likely reflecting reshoring trends and tighter domestic supply. Hong Kong saw explosive but volatile growth (coefficient of variation of 1.11), potentially indicating re-export intermediation. The UK's rise of 84.6% partly reflects post-Brexit trade restructuring, where flows that previously moved intra-EU are now recorded as extra-EU imports.

Export destinations reoriented toward Switzerland while Eastern European markets eroded

On the export side, Switzerland emerged as the dominant partner, growing from €5.7 million to €9.4 million (+65.5%) — now accounting for nearly half of all EU azo exports by value. This likely reflects Switzerland's large pharmaceutical and fine-chemical sector sourcing intermediates from the EU.

Partner 2015 (€M) 2025 (€M) Change (%)
Switzerland 5.7 9.4 +65.5%
United Kingdom 4.7 2.2 −53.9%
United States 4.1 2.2 −46.7%
Israel 0.4 0.7 +100.7%
Serbia 0.1 0.4 +365.3%
Ukraine 0.8 0.2 −72.8%
Russian Federation 0.7 0.2 −64.7%

The contraction in exports to Ukraine (−72.8%) and Russia (−64.7%) is consistent with the geopolitical disruptions following 2022. The UK decline (−53.9%) mirrors the import-side effect: trade reclassification post-Brexit, combined with possible demand shifts. Serbia and Israel bucked the downward trend, with Serbia growing dramatically from a low base.

Germany remained the EU's trade hub but faced declining import volumes

Among EU Member States, Germany dominated both imports and exports, though its import value contracted from €22.9 million to €17.5 million (−23.8%). Italy and Spain maintained stable positions. Poland saw the most dramatic change among importers, surging from €0.2 million to €4.6 million (+2,078%), suggesting a rapid build-up of chemical processing capacity in Central Europe. On the export side, Germany still accounted for over half of EU exports, while the Netherlands saw a steep decline (−78.3%) and Spain emerged as a growing exporter (+84.3%).

Market concentration increased on both sides of the trade ledger

The Herfindahl-Hirschman Index (HHI) for imports by value rose from 2,280 to 2,902 (+27.3%), while the export HHI surged from 1,703 to 2,791 (+63.9%). Both values now exceed the 2,500 threshold that US antitrust authorities consider indicative of a "highly concentrated" market. This rising concentration implies greater vulnerability to disruption from any single supplier or buyer — a point explored further in the volatility section below.

HHI (by value) 2015 2025 Change (%)
Imports 2,280 2,902 +27.3%
Exports 1,703 2,791 +63.9%

III. Volatility, price shocks, and structural vulnerability

Asian suppliers showed lower price volatility than smaller or more distant partners

The coefficient of variation (CV) of import flows reveals that the EU's two largest suppliers — China (CV: 0.12) and Indonesia (CV: 0.14) — offered the most stable trade flows, reflecting mature, high-volume commercial relationships. By contrast, smaller partners exhibited much greater volatility: Türkiye (CV: 2.06), Norway (CV: 1.63), and Hong Kong (CV: 1.11) showed highly erratic patterns. On the export side, Switzerland (CV: 0.18) and the UK (CV: 0.13) were the most stable destinations, while Israel (CV: 1.03) and Mexico (CV: 0.72) were more unpredictable.

This pattern is economically intuitive: large-scale, long-term supply contracts tend to reduce volatility, while spot-market or opportunistic trade with smaller partners produces wider swings.

Three major price shocks were detected between 2022 and 2023

The volatility analysis identified three significant price shock events:

Event Flow Year Price shift (%) Abnormality score Value share
China (imports) Imports 2022 +74.0% 4.8 57.9%
Serbia (exports) Exports 2022 +68.4% 9.7 1.8%
Israel (exports) Exports 2023 −17.6% 8.7 3.3%

The 2022 China import price shock — a 74% spike affecting nearly 58% of import value — is the most consequential. It coincides with the global energy and supply-chain crisis triggered by the post-COVID recovery and the onset of the Russia-Ukraine conflict. Given that azo compound production is energy-intensive and China's chemical sector faced intermittent disruptions during this period, the price surge is consistent with broader market conditions. The Serbian export shock, while high in abnormality, affected a small share of trade and may reflect a one-off transaction rather than a structural shift. The 2023 Israeli price drop likely reflects normalisation after the 2022 spike.

Specialisation patterns reveal a two-tier European production landscape

The revealed comparative advantage analysis for 2025 shows a highly uneven distribution of specialisation across EU members. Latvia displays an extreme RCA of 84.9 (though from a very small production base), while Belgium (RCA: 2.01) and Spain (RCA: 1.98) show meaningful specialisation. Germany, the largest producer, has an RCA just below 1.0 (0.90), indicating it is not a net specialist in this product — consistent with its role as a broad-based chemical producer rather than one focused on azo compounds specifically.

Member State RCA (2025) RSCA (2025) Production share
Latvia 84.86 0.977 0.3%
Belgium 2.01 0.336 17.0%
Spain 1.98 0.330 11.5%
Italy 1.41 0.171 11.3%
Germany 0.90 −0.051 19.1%

Several Member States — including Romania, Estonia, and Croatia — show essentially zero specialisation and negligible production, confirming that azo compound manufacturing is concentrated in a handful of Western European countries.


Conclusion

Over the 2015–2025 decade, the EU's trade in azo compounds (CN 2927) underwent significant structural transformation. While the headline trade deficit remained relatively stable in nominal terms, the underlying dynamics reveal growing external dependence: net import reliance more than quadrupled to nearly 72%, and import market concentration (HHI) rose above the "highly concentrated" threshold. China and Indonesia consolidated their positions as the dominant suppliers, while the EU's export base became narrower and more reliant on Switzerland as a high-value destination.

The price dynamics tell a story of divergence: export unit values rose by 18% even as volumes fell, suggesting the EU is retreating from commodity segments and concentrating on higher-margin, specialised products. Import prices, by contrast, remained flat — until the 2022 energy crisis triggered a 74% spike in Chinese-origin prices, exposing the EU's vulnerability to supply-chain shocks in a concentrated market.

Looking ahead, the combination of rising import dependence, increasing supplier concentration, and demonstrated price volatility points to a market where strategic stockpiling, diversification of sourcing, and support for domestic production capacity may become increasingly important policy considerations — particularly given the chemical sector's relevance to pharmaceuticals, agriculture, and advanced manufacturing.

Generated on 2026-08-07. Figures reflect Eurostat data at generation time and do not include later revisions.

Auto-generated: this report is meant to accelerate, but not to replace, human analysis.

If you need advice on European trade policy, or representation for your interests in Brussels, please contact me at support@tradedashboard.eu. You can find my CV at this address.